455 related articles for article (PubMed ID: 21629293)
1. The productivity crisis in pharmaceutical R&D.
Pammolli F; Magazzini L; Riccaboni M
Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293
[TBL] [Abstract][Full Text] [Related]
2. How to improve R&D productivity: the pharmaceutical industry's grand challenge.
Paul SM; Mytelka DS; Dunwiddie CT; Persinger CC; Munos BH; Lindborg SR; Schacht AL
Nat Rev Drug Discov; 2010 Mar; 9(3):203-14. PubMed ID: 20168317
[TBL] [Abstract][Full Text] [Related]
3. R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
Schuhmacher A; Wilisch L; Kuss M; Kandelbauer A; Hinder M; Gassmann O
Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459
[TBL] [Abstract][Full Text] [Related]
4. Translational regenerative medicine research: essential to discovery and outcome.
Mason C; Dunnill P
Regen Med; 2007 May; 2(3):227-9. PubMed ID: 17511558
[No Abstract] [Full Text] [Related]
5. R&D productivity rides again?
Lendrem D; Senn SJ; Lendrem BC; Isaacs JD
Pharm Stat; 2015; 14(1):1-3. PubMed ID: 25336017
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics in late clinical development.
Fernandes P; Martens E
Biochem Pharmacol; 2017 Jun; 133():152-163. PubMed ID: 27687641
[TBL] [Abstract][Full Text] [Related]
7. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
Shimura H; Masuda S; Kimura H
Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
[TBL] [Abstract][Full Text] [Related]
8. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
Grabowski H
Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
[TBL] [Abstract][Full Text] [Related]
9. Discontinued drugs in 2010: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
[TBL] [Abstract][Full Text] [Related]
10. Research and development productivity map: visualization of industry status.
Shimura H; Masuda S; Kimura H
J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
[TBL] [Abstract][Full Text] [Related]
11. The endless frontier? The recent increase of R&D productivity in pharmaceuticals.
Pammolli F; Righetto L; Abrignani S; Pani L; Pelicci PG; Rabosio E
J Transl Med; 2020 Apr; 18(1):162. PubMed ID: 32272953
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial R&D incentives.
Laxminarayan R; Powers JH
Nat Rev Drug Discov; 2011 Sep; 10(10):727-8. PubMed ID: 21959280
[No Abstract] [Full Text] [Related]
13. Should financial incentives be used to differentially reward 'me-too' and innovative drugs?
Pekarsky B
Pharmacoeconomics; 2010; 28(1):1-17. PubMed ID: 20014872
[TBL] [Abstract][Full Text] [Related]
14. How to revive breakthrough innovation in the pharmaceutical industry.
Munos BH; Chin WW
Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
[TBL] [Abstract][Full Text] [Related]
15. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
16. Precompetitive activity to address the biological data needs of drug discovery.
Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M
Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293
[No Abstract] [Full Text] [Related]
17. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
18. What are the economic barriers of antibiotic R&D and how can we overcome them?
Renwick M; Mossialos E
Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625
[No Abstract] [Full Text] [Related]
19. Trends in risks associated with new drug development: success rates for investigational drugs.
DiMasi JA; Feldman L; Seckler A; Wilson A
Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
